OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, and Scipher Medicine, which ...

Patients with late-onset rheumatoid arthritis face poorer physical outcomes and higher risks of death and malignancy, ...

In the study of 200 RA patients enrolled in the so-called BRASS registry at Brigham & Women's Hospital, disease activity was categorized into three groups of Clinical Disease Activity Index (CDAI ...

Those who finished at-least 5 years followed up were eligible in this study. Clinical data, including RA disease activity (DAS28-ESR, DAS28-ESR, SDAI and CDAI) and physical function indicator (HAQ-DI) ...

Disease Activity (CDAI): • Both arms achieved significant early gains ... In conclusion, patients with late-onset rheumatoid arthritis demonstrated similar disease activity improvements as ...

Objective Remission in rheumatoid arthritis (RA) is an increasingly attainable goal ... It was not the case for other index measures that defined remission, such as the SDAI or CDAI, where results ...

When comparing sexes, no differences were found in disease activity in CD measured through CDAI (p=0.66) nor in UC measured by the ... Wagtmans MJ, Verspaget HW, Lamers CB, Hogezand RA. Gender-related ...

With nearly 30% of patients enrolled in each arm having a CDAI <150 at study entry ... comment on the risk of lymphoma with MTX cotreatment in IBD patients. Adult rheumatoid arthritis data show that ...

Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...

Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...